Last reviewed · How we verify
Medullary thyroid carcinoma
Approved treatments
- Caprelsa · Sanofi
Caprelsa works by blocking a specific protein that helps cancer cells grow and spread. - Cometriq · Exelixis
Cometriq blocks the VEGFR2 pathway to prevent tumor growth and angiogenesis. - Retevmo · Eli Lilly
Retevmo works by blocking the activity of the RET protein, which is involved in the growth and spread of cancer cells. - Zactima · Barbara Ann Karmanos Cancer Institute
- Cometriq · Exelixis Inc
Cometriq works by blocking the activity of vascular endothelial growth factor receptor 2, a protein involved in tumor growth and angiogenesis. - Gavreto · Rigel Pharms
Pralsetinib inhibits RET kinase and its oncogenic fusions/mutations, blocking downstream signaling and reducing tumor growth. - Caprelsa · Genzyme, a Sanofi Company
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Medullary thyroid carcinoma patent landscape — cliff calendar, originator estates, attackable patents
- Medullary thyroid carcinoma treatment landscape brief
- Medullary thyroid carcinoma treatment updates RSS
Frequently asked questions about Medullary thyroid carcinoma
What drugs treat Medullary thyroid carcinoma?
Tracked treatments include Caprelsa, Cometriq, Retevmo, Zactima, Gavreto.
What is the treatment for Medullary thyroid carcinoma?
Standard treatment for Medullary thyroid carcinoma includes Caprelsa, Cometriq, Retevmo, Zactima, Gavreto. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Medullary thyroid carcinoma patent cliff · Medullary thyroid carcinoma CI report
- Treatment: Caprelsa · Sanofi
- Treatment: Cometriq · Exelixis
- Treatment: Retevmo · Eli Lilly
- Treatment: Zactima · Barbara Ann Karmanos Cancer Institute
- Treatment: Cometriq · Exelixis Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing